Method for the purification of raw caprolactam
    1.
    发明授权
    Method for the purification of raw caprolactam 失效
    纯己内酰胺纯化方法

    公开(公告)号:US4314940A

    公开(公告)日:1982-02-09

    申请号:US142860

    申请日:1980-04-21

    CPC classification number: C07D201/16

    Abstract: A method for the purification of raw caprolactam containing primary amidesf the formula ##STR1## wherein R is a hydrocarbon radical having 1-14 carbon atoms is described. The raw caprolactam is treated with at least one compound containing at least one hydroxyl group, in an amount of at least 20% by weight with respect to the raw caprolactam, at a temperature equal to or higher than that at which the ammonia, which is a part of the amide of formula I, is liberated. The caprolactam is then separated and isolated from the hydroxyl containing compound by known methods.

    Abstract translation: 描述了含有其中R为具有1-14个碳原子的烃基的式(Ⅰ)的伯酰胺的原始己内酰胺的纯化方法。 在等于或高于氨的温度下,将至少一种含有至少一个羟基的化合物与至少20重量%的量相对于原己内酰胺一起处理, 一部分式I的酰胺被释放出来。 然后通过已知方法将己内酰胺分离并从含羟基化合物中分离。

    Process for the reduction of pterins
    2.
    发明授权
    Process for the reduction of pterins 有权
    减少蝶呤的方法

    公开(公告)号:US6162914A

    公开(公告)日:2000-12-19

    申请号:US306996

    申请日:1999-05-07

    CPC classification number: C07D475/04

    Abstract: The inventive process for the reduction of pterins by means of an alkali metal boron hydride in water to the corresponding 5,6,7,8-tetrahydropterins is characterized in that the reduction is carried out in the presence of a catalytical amount of a water-soluble Pb(II)-salt.

    Abstract translation: 通过碱金属硼氢化物在水中将蝶呤还原成相应的5,6,7,8-四氢内啡肽的本发明方法的特征在于还原是在催化量的水 - 可溶性Pb(II) - 盐。

Patent Agency Ranking